• Nie Znaleziono Wyników

Parameters of platelet indices in young patients with ST elevation myocardial infarction. Commentary to the article: “Platelet distribution width and plateletcrit: novel biomarkers of ST elevation myocardial infarction in young patients”

N/A
N/A
Protected

Academic year: 2022

Share "Parameters of platelet indices in young patients with ST elevation myocardial infarction. Commentary to the article: “Platelet distribution width and plateletcrit: novel biomarkers of ST elevation myocardial infarction in young patients”"

Copied!
1
0
0

Pełen tekst

(1)

www.kardiologiapolska.pl

Kardiologia Polska 2018; 76, 1: 227; DOI: 10.5603/KP.2018.0022 ISSN 0022–9032

LIST DO REDAKCJI / LETTER TO THE EDITOR

Address for correspondence:

Tarik Yildirim, MD, Muğla Sıtkı Koçman Üniversitesi Tıp Fakültesi Orhaniye Mah. Haluk Özsoy Cad.48000, Muğla, Turkey, tel: +905322505102, e-mail: kdrtarik@gmail.com

Kardiologia Polska Copyright © Polskie Towarzystwo Kardiologiczne 2018

Parameters of platelet indices in young patients with ST elevation myocardial infarction.

Commentary to the article: “Platelet distribution width and plateletcrit: novel biomarkers

of ST elevation myocardial infarction in young patients”

published in “Kardiologia Polska” 2017; 75(10): 1005–1012 (doi: 10.5603/KP.a2017.0135) Tarik Yildirim, Fatih Akin, Ibrahim Altun, Gokhan Ergun, Seda Elcim Yildirim, Mustafa Ozcan Soylu

Department of Cardiology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla, Turkey

We have read with great interest the article by Cetin et al. [1] on “Platelet distribution width and plateletcrit: novel biomarkers of ST elevation myocardial infarction in young pa- tients”, which is an important cross-sectional study. However, we have some suggestions about this study.

The authors [1] did not explain whether patients who received antiaggregant and anticoagulant treatment were involved in or excluded from this study. Antiaggregant and anticoagulant drugs may influence the platelet indices [2].

The authors also did not mention how the blood sample was anticoagulated for the whole blood count or the time elapsed after collection for measurement of the time of platelet indices. Lance et al. [3] reported that platelets stored in citrate are significantly smaller compared to those stored in ethylenediaminetetraacetic acid (EDTA). Platelets swell until 120 min in EDTA and until 60 min in citrate [3]. Timing is important when measuring platelet indices. The optimal measuring time of mean platelet volume (MPV) is 120 min after veinpuncture because MPV increases over time. It was also reported that this increase was proportional with the delay in time [4].

The authors found that the levels of MPV, platelet distri- bution width (PDW), and plateletcrit (PCT) are significantly higher in the first group than in other groups. In the discus- sion PCT and PDW are emphasised, but there is no debate about MPV. Plateletcrit is a measure of total platelet mass

(total platelet mass = platelet count × MPV/107). They did not find significant differences for platelet counts among the groups. Therefore, we think that MPV is the most effective parameter on PCT.

Lastly, they performed multivariate logistic regression analysis, and the respective odds ratios with 95% confi- dence intervals were calculated. Did the authors compare the young ST elevation myocardial infarction (STEMI) group with a non-young STEMI group or a control group? It would be useful if the authors reported clearly about this analysis.

Conflict of interest: none declared References

1. Cetin MS, Ozcan Cetin EH, Akdi A, et al. Platelet distribu- tion width and plateletcrit: novel biomarkers of ST elevation myocardial infarction in young patients. Kardiol Pol. 2017;

75(10): 1005–1012, doi: 10.5603/KP.a2017.0135, indexed in Pubmed: 28715073.

2. Haungsaithong R, Udommongkol C, Nidhinandana S, et al. The changes in mean platelet volume after using of antiplatelet drugs in acute ischemic stroke: a randomized controlled trial. J Med Assoc Thai. 2015; 98(9): 852–857, indexed in Pubmed: 26591394.

3. Lancé MD, van Oerle R, Henskens YMC, et al. Do we need time adjusted mean platelet volume measurements? Lab Hematol.

2010; 16(3): 28–31, doi: 10.1532/LH96.10011, indexed in Pub- med: 20858586.

4. Varol E, Ozaydin M. Mean platelet volume measurement in patients with hypercholesterolemia: a methodological issue.

Angiology. 2013; 64(8): 626, doi: 10.1177/0003319713490824, indexed in Pubmed: 23709475.

Cytaty

Powiązane dokumenty

Typical risk factors of coronary heart disease in young patients were slightly different from those in the older population, namely dia- betes mellitus, arterial hypertension,

Although primary percutaneous coronary intervention (pPCI) is the main method of reperfusion therapy in patients with ST ‑segment elevation myocardial infarction (STEMI), there

RESULTS The main findings of this study were as follows: 1) 31.5% of patients had at least 1 STEMI equivalent, mostly the N ‑wave in lead II, III, or aVF; 2) the most common

However, when referral for emergent reperfusion therapy is based only on the ECG criteria for STEMI or NSTEMI diagnosis, we lose around 25% of patients with acute total occlusion

We had reported in the statistical analysis section that multivariate logistic regression analysis had been performed to evaluate the importance of platelet indices in predict-

Methods: This cross-sectional study consisted of 565 subjects who were classified into three groups: group 1 (168 young patients with STEMI), group 2 (173 non-young patients

The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous

Patients with both acute hyperglycaemia and the leukocyte count greater than or equal to the median in the overall study group had a higher in-hospital risk of death and/or